Journal Information
Vol. 155. Issue 4.
Pages 184 (August 2020)
Share
Download PDF
More article options
Vol. 155. Issue 4.
Pages 184 (August 2020)
Letter to the Editor
Is it necessary to modify the clinical trials about osteoporosis? The serious problem of denosumab
¿Es necesario modificar los ensayos clínicos sobre osteoporosis? El grave problema de denosumab
Visits
2
Manuel Sosa Henríqueza,b,
, M. Jesús Gómez de Tejada Romeroc, Oscar Torregrosa Suaud
Corresponding author
a Universidad de Las Palmas de Gran Canaria, Departamento de Ciencias Médicas y Quirúrgicas, Grupo de investigación en osteoporosis y metabolismo mineral, Las Palmas de Gran Canaria, Las Palmas, Spain
b Unidad Metabólica Ósea, Hospital Universitario Insular, Las Palmas de Gran Canaria, Las Palmas, Spain
c Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain
d Servicio de Medicina Interna, Hospital Universitario de Elche. Elche, Alicante, Spain
This item has received
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail